what is the average weight loss on tirzepatide Who Qualifies for Medical Treatment? Tirzepatide outperformed semaglutide weight-loss drug

The newest weight-loss drug, called retatrutide, could help people lose 30% of body weight, based on recent clinical trials

Experts say that with patent expiry, the generic semaglutide opportunity in India alone could be worth over 50 billion (about USD 600 million) in the coming years as multiple players enter the segment

Tirzepatide clinical trial results The SURMOUNT-1 trial tested tirzepatide in adults with obesity or overweight without type 2 diabetes

The gastrointestinal effects of GLP-1 agonists require careful consideration in the context of an already compromised digestive system, and UK product licences include specific cautions regarding use in severe gastrointestinal disease